BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 13, 2006
View Archived Issues
Protherics to acquire CoVaccine's novel adjuvant for angiotensin vaccine
Read More
Development & manufacturing agreement for A&G anti-GP88 cancer therapeutic antibody
Read More
MorphoSys and OncoMed sign HuCAL agreement for cancer research
Read More
NOMAC/E2 combined oral contraceptive enters phase III
Read More
SPARC study of satraplatin cleared to continue to completion
Read More
HuMax-CD38 blocks ectoenzymatic activity of CD38 in preclinical studies
Read More
Criterion reached for interim efficacy statistical analysis of PRECISE study
Read More
ProLindac studied in phase II trial for ovarian cancer
Read More
AstraZeneca updates status of development portfolio
Read More
Phase II data on GVAX cancer immunotherapy in CML reported
Read More
Phase I data on BIBF-1120 for advanced solid tumors
Read More
DN-101 shows activity in NSCLC study
Read More
Pharming's acquisition of DNage delayed by appeal
Read More
MORAb-003 begins phase II studies
Read More
MRX-5 improves IBD symptoms in preclinical studies
Read More
Neumune cleared for clinical study in patients at risk of nosocomial infections
Read More
Medicine status for Mologen's cell-based gene therapy for kidney cancer
Read More
Orphan drug designation for ropidoxuridine in malignant glioma
Read More
U.K.'s NICE recommends use of Herceptin
Read More
BioDelivery Sciences discusses Emezine path forward with FDA
Read More
Novel therapeutic agents for respiratory disorders disclosed in recent patents
Read More
Novel agents for urological disorders disclosed in recent patent literature
Read More
Recent patents report novel analgesic agents
Read More
Encouraging early clinical data reported on SGN-40 in Atlanta
Read More
Elacyt safety improved on new administration schedule tested in patients with solid tumors
Read More
Initial results of phase I trial of Patrin and dacarbazine in patients with solid tumors
Read More
MDX-214, a novel immunotherapeutic strategy for EGFR+ tumors
Read More
Axitinib demonstrates promising activity in pancreatic and thyroid cancer
Read More
DPP-IV inhibitor developed at Point Therapeutics shows antidiabetic potential in preclinical studies
Read More
New vitamin D receptor modulators show efficacy in a preclinical model of psoriasis
Read More
Folate-mitomycin conjugates suppress tumor growth in combination with paclitaxel
Read More
